FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2593166706> ?p ?o ?g. }

• W2593166706 endingPage "334" @default.
• W2593166706 startingPage "329" @default.
• W2593166706 abstract "While PET using F-FDG is most commonly used for imaging malignant tumors, vaccination is known to cause transient inflammation of lymph nodes inducing positive findings on F-FDG PET scans. The pattern, magnitude, and duration of lymph node activation following vaccination have not been clearly defined. Furthermore, the addition of adjuvants to vaccines can further enhance the immune response. The presented study was designed to define lymph node activation following administration of the Food and Drug Administration-licensed human papillomavirus vaccines, Cervarix and Gardasil, which contain similar antigens with different adjuvants.Twenty-seven women aged 18 to 25 years were randomized to receive either Cervarix or Gardasil in the clinical trial VRC 900. Fifteen subjects participated in the PET/CT portion of the trial and received scans of lymph node activation at prevaccination and 1 week (8-14 days) and 1 month (23-36 days) after the first or third vaccination.PET/CT scans revealed that all vaccine recipients had ipsilateral axillary lymph node activity. Three of 4 Cervarix recipients also showed contralateral lymph node activity 1 month after the first vaccination. For both Cervarix and Gardasil, the SUV activity resolved over time, with activity extended up to day 37 after the first and third vaccinations.Following intramuscular vaccination, there were no major differences between duration of uptake and intensity of SUV between Cervarix and Gardasil recipients in ipsilateral axillary lymph nodes. Contralateral node activation was detected up to 1 month after the first vaccination in Cervarix recipients only, possibly reflecting differences in vaccine adjuvant formulation." @default.
• W2593166706 created "2017-03-16" @default.
• W2593166706 creator A5003805101 @default.
• W2593166706 creator A5008829184 @default.
• W2593166706 creator A5011534601 @default.
• W2593166706 creator A5015755209 @default.
• W2593166706 creator A5020230187 @default.
• W2593166706 creator A5021608465 @default.
• W2593166706 creator A5036040601 @default.
• W2593166706 creator A5041065135 @default.
• W2593166706 creator A5044479295 @default.
• W2593166706 creator A5046821811 @default.
• W2593166706 creator A5052456314 @default.
• W2593166706 creator A5062024966 @default.
• W2593166706 creator A5065400481 @default.
• W2593166706 creator A5077598738 @default.
• W2593166706 creator A5087548647 @default.
• W2593166706 date "2017-05-01" @default.
• W2593166706 modified "2023-10-03" @default.
• W2593166706 title "Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses" @default.
• W2593166706 cites W1963888311 @default.
• W2593166706 cites W1979766933 @default.
• W2593166706 cites W1983264793 @default.
• W2593166706 cites W1991378124 @default.
• W2593166706 cites W1998338807 @default.
• W2593166706 cites W2002636409 @default.
• W2593166706 cites W2006287503 @default.
• W2593166706 cites W2013493538 @default.
• W2593166706 cites W2019453584 @default.
• W2593166706 cites W2055024864 @default.
• W2593166706 cites W2056922374 @default.
• W2593166706 cites W2066081355 @default.
• W2593166706 cites W2067560492 @default.
• W2593166706 cites W2069143946 @default.
• W2593166706 cites W2086404290 @default.
• W2593166706 cites W2114391710 @default.
• W2593166706 cites W2120416394 @default.
• W2593166706 cites W2162086037 @default.
• W2593166706 doi "https://doi.org/10.1097/rlu.0000000000001603" @default.
• W2593166706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28288041" @default.
• W2593166706 hasPublicationYear "2017" @default.
• W2593166706 type Work @default.
• W2593166706 sameAs 2593166706 @default.
• W2593166706 citedByCount "61" @default.
• W2593166706 countsByYear W25931667062017 @default.
• W2593166706 countsByYear W25931667062018 @default.
• W2593166706 countsByYear W25931667062019 @default.
• W2593166706 countsByYear W25931667062020 @default.
• W2593166706 countsByYear W25931667062021 @default.
• W2593166706 countsByYear W25931667062022 @default.
• W2593166706 countsByYear W25931667062023 @default.
• W2593166706 crossrefType "journal-article" @default.
• W2593166706 hasAuthorship W2593166706A5003805101 @default.
• W2593166706 hasAuthorship W2593166706A5008829184 @default.
• W2593166706 hasAuthorship W2593166706A5011534601 @default.
• W2593166706 hasAuthorship W2593166706A5015755209 @default.
• W2593166706 hasAuthorship W2593166706A5020230187 @default.
• W2593166706 hasAuthorship W2593166706A5021608465 @default.
• W2593166706 hasAuthorship W2593166706A5036040601 @default.
• W2593166706 hasAuthorship W2593166706A5041065135 @default.
• W2593166706 hasAuthorship W2593166706A5044479295 @default.
• W2593166706 hasAuthorship W2593166706A5046821811 @default.
• W2593166706 hasAuthorship W2593166706A5052456314 @default.
• W2593166706 hasAuthorship W2593166706A5062024966 @default.
• W2593166706 hasAuthorship W2593166706A5065400481 @default.
• W2593166706 hasAuthorship W2593166706A5077598738 @default.
• W2593166706 hasAuthorship W2593166706A5087548647 @default.
• W2593166706 hasConcept C121608353 @default.
• W2593166706 hasConcept C126322002 @default.
• W2593166706 hasConcept C142724271 @default.
• W2593166706 hasConcept C203014093 @default.
• W2593166706 hasConcept C22070199 @default.
• W2593166706 hasConcept C2777265743 @default.
• W2593166706 hasConcept C2777649267 @default.
• W2593166706 hasConcept C2777863537 @default.
• W2593166706 hasConcept C2778220009 @default.
• W2593166706 hasConcept C2779720271 @default.
• W2593166706 hasConcept C2780849966 @default.
• W2593166706 hasConcept C530470458 @default.
• W2593166706 hasConcept C71924100 @default.
• W2593166706 hasConceptScore W2593166706C121608353 @default.
• W2593166706 hasConceptScore W2593166706C126322002 @default.
• W2593166706 hasConceptScore W2593166706C142724271 @default.
• W2593166706 hasConceptScore W2593166706C203014093 @default.
• W2593166706 hasConceptScore W2593166706C22070199 @default.
• W2593166706 hasConceptScore W2593166706C2777265743 @default.
• W2593166706 hasConceptScore W2593166706C2777649267 @default.
• W2593166706 hasConceptScore W2593166706C2777863537 @default.
• W2593166706 hasConceptScore W2593166706C2778220009 @default.
• W2593166706 hasConceptScore W2593166706C2779720271 @default.
• W2593166706 hasConceptScore W2593166706C2780849966 @default.
• W2593166706 hasConceptScore W2593166706C530470458 @default.
• W2593166706 hasConceptScore W2593166706C71924100 @default.
• W2593166706 hasIssue "5" @default.
• W2593166706 hasLocation W25931667061 @default.
• W2593166706 hasLocation W25931667062 @default.
• W2593166706 hasOpenAccess W2593166706 @default.
• W2593166706 hasPrimaryLocation W25931667061 @default.

• next